Document is current
Any future updates will be listed below
-
Authors
De Vos, Willem M. https://orcid.org/0000-0002-0273-3166
Nguyen Trung, Minh https://orcid.org/0000-0003-3100-9609
Davids, Mark https://orcid.org/0000-0003-3081-9124
Liu, Guizhen
Rios-Morales, Melany
Jessen, Henning https://orcid.org/0000-0002-1025-9484
Fiedler, Dorothea https://orcid.org/0000-0002-0798-946X
Nieuwdorp, Max
Bui, Thi Phuong Nam https://orcid.org/0000-0001-5366-5960
- License Information
-
More Information
Article History
Received: 25 August 2023
Accepted: 4 April 2024
First Online: 10 June 2024
Competing interests
: W.M.D.V. and M.N. are founders and members of the Scientific Advisory Board of Caelus Pharmaceuticals, the Netherlands. However, none of these possible conflicts of interest bear direct relations to the outcomes of this specific study. The other authors declare no competing interests.
